Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) - Related Studies

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)

This study has been completed.

Study NCT00107770. Last updated on October 10, 2008. Information provided by Department of Veterans Affairs

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Amyotrophic Lateral Sclerosis

2	Additional conditions recognized in this trial
		Motor Neuron Disease
		Sclerosis

3	More general conditions related to this trial
		Central Nervous System Diseases
		Nervous System Diseases
		Neurodegenerative Diseases
		Neuromuscular Diseases
		Pathologic Processes
		Spinal Cord Diseases

4	Interventions listed in this trial
		sodium phenylbutyrate

5	Additional drug interventions recognized in this trial
		4-phenylbutyric acid

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Department of Veterans Affairs
		Muscular Dystrophy Association